Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | VDR | P11473 | 1/20 | 0.42 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.39 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.39 |
| ▸ | ITGAL | P20701 | 1/20 | 0.39 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30830197 | 1.00 | KDM4E (0.56) | KDM4EHSD17B10CYP1A2GLACYP2C9 | |
| Water SCHEMBL16634424 | 0.98 | KDM4E (0.54) | KDM4EHSD17B10CYP1A2GLACYP2C9 | |
| SCHEMBL29269339 | 0.91 | HPRT1 (0.50) | KDM4EHSD17B10CYP1A2GLACYP2C9 | |
| SCHEMBL29670013 | 0.89 | KDM4E (0.53) | KDM4EHSD17B10CYP1A2GLACYP2C9 | |
| SCHEMBL30003445 | 0.89 | KDM4E (0.53) | KDM4EHSD17B10CYP1A2GLACYP2C9 | |
| SCHEMBL371993 | 0.89 | KDM4E (0.53) | KDM4EHSD17B10CYP1A2GLACYP2C9 | |
| Acetic Acid SCHEMBL11711913 | 0.88 | KDM4E (0.50) | KDM4EHSD17B10CYP1A2GLACYP2C9 | |
| SCHEMBL14158873 | 0.85 | KDM4E (0.41) | KDM4EHSD17B10CYP1A2GLACYP2C9 | |
| SCHEMBL1123737 | 0.81 | KDM4E (0.53) | KDM4EHSD17B10CYP1A2GLACYP2C9 | |
| SCHEMBL372146 | 0.80 | HPRT1 (0.47) | KDM4EHSD17B10CYP1A2GLACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | SYMRISE AG (DE) | 2026-02-19 | — | — | US | disclosed |
| WO-2025051340-A1 | TRPM8 MODULATORS AND RELATED METHOD FOR MODULATING TRPM8 RECEPTORS | SYMRISE AG (DE) | 2025-03-13 | — | — | WO | disclosed |
| US-20230212483-A1 | Improvements in or Relating to Organic Compounds | GIVAUDAN SA (CH) | 2023-07-06 | — | — | US | disclosed |
| CN-113861169-A | Polysubstituted naphtho-dihydrofuran compound, preparation method and application thereof | 西华大学 | 2021-12-31 | — | — | CN | disclosed |
| US-10806683-B2 | Encapsulated perfume compositions | GIVAUDAN SA (CH) | 2020-10-20 | — | — | US | disclosed |
| US-10722857-B2 | Encapsulated perfume compositions | GIVAUDAN S.A. (CH) | 2020-07-28 | — | — | US | disclosed |
| US-10537868-B2 | Microcapsules | GIVAUDAN S.A. (CH) | 2020-01-21 | — | — | US | disclosed |
| US-20180185808-A1 | MICROCAPSULES | GIVAUDAN SA (CH) | 2018-07-05 | — | — | US | disclosed |
| US-20180177689-A1 | IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS | GIVAUDAN S.A. (CH) | 2018-06-28 | — | — | US | disclosed |
| US-20180169603-A1 | IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS | GIVAUDAN S.A. (CH) | 2018-06-21 | — | — | US | disclosed |
| US-20140357682-A1 | ANDROGEN RECEPTOR LIGANDS | The Provost, Fellows, Foundation Scholars, & the Other Members of Board, of The College of the Holy (IE) | 2014-12-04 | — | — | US | disclosed |
| WO-2013076275-A1 | ANDROGEN RECEPTOR LIGANDS | THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIV.TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (IE) | 2013-05-30 | — | — | WO | disclosed |
| US-8034949-B2 | Pyrrolidine compound and a process for preparing the same | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2011-10-11 | — | — | US | disclosed |
| US-8034949-B2 | Pyrrolidine compound and a process for preparing the same | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2011-10-11 | — | — | US | disclosed |
| US-20070167440-A1 | Novel pyrrolidine compound and a process for preparing the same | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-07-19 | — | — | US | disclosed |
| US-20070167440-A1 | Novel pyrrolidine compound and a process for preparing the same | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-07-19 | — | — | US | disclosed |
| EP-1222174-A1 | IMIDAZOL-4-YLMETHANOLS USED AS INHIBITORS OF STEROID C17-20 LYASE | Takeda Chemical Industries, Ltd. (JP) | 2002-07-17 | — | — | EP | disclosed |
| WO-2001030762-A1 | IMIDAZOL-4-YLMETHANOLS USE AS INHIBITORS OF STEROID C17-20 LYASE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-05-03 | — | — | WO | disclosed |
| CN-1103866-A | Nes pesticides | RHONE POULENC AGRICULTURE (GB) | 1995-06-21 | — | — | CN | disclosed |
| EP-0023080-B1 | SUBSTITUTED 2,7-DIOXO-2,7-DIHYDROBENZO(1:2-B; 5,6-B1)DIFURAN OR DIPYRROLE DYESTUFFS, PROCESSES FOR THEIR PREPARATION AND THEIR USE FOR THE COLOURATION OF AROMATIC POLYESTER TEXTILE MATERIALS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1983-07-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070167440-A1 | Novel pyrrolidine compound and a process for preparing the same | CNR1, CNR2, OPRD1 | KDM4E 535/4885HSD17B10 1741/4885CYP1A2 580/4885 |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | RBP4, LRAT, RARB | KDM4E 1000/4885HSD17B10 61/4885CYP1A2 3874/4885 |
| US-20140357682-A1 | ANDROGEN RECEPTOR LIGANDS | AR, NR5A1, SHBG | KDM4E 3767/4885HSD17B10 333/4885CYP1A2 1380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.